3rd Quarter - Report

THE SMITH-FREE GROUP, LLC for HCA

Firm
Client
HCA
Income
$130,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions pertinent to health care group purchasing organizations (GPOs) role in helping to prevent drug shortages Monitored HR 277 American Health Care Reform Act of 2017 Monitored S 297 Increasing Competition in Pharmaceuticals Act Monitored HR 749 Lower Drug Costs through Competition Act Monitored HR 208 Ensuring Health Care Opportunities Act Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act Monitored S 191 Patient Freedom Act of 2017 Monitored S 761 Health Care Options Act of 2017 Monitored HR 1933 Health Care Options Act of 2017 Monitored HR 1628 American Health Care Act of 2017 Monitored Bipartisan Health Care Stabilization Act 2018 (proposed Alexander-Murray legislation) Monitored S 2312 Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act Monitored politically appointed Senate-confirmed positions Monitored S 3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 Monitored HR 4191 HHS Cybersecurity Modernization Act Monitored HR 4710 340B PAUSE Act Monitored S 2453 Ensuring the Value of the 340B Program Act of 2018 Monitored H.R.4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes Monitored HR 6 SUPPORT for Patients and Communities Act

LobbyistCovered position, as disclosed
JACK S DEUSER —
JAMES C FREE —
ROBERT HICKMOTT —
TREVOR W. KOLEGO —
W. TIMOTHY LOCKE —
SUMMER MERSINGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4191 (115th), H.R. 1628 (115th), H.R. 6 (115th), H.R. 1933 (115th), H.R. 4392 (115th), H.R. 749 (115th), H.R. 4710 (115th), H.R. 277 (115th), H.R. 208 (115th), H.R. 2562 (115th)

Medicare/Medicaid MMM

Discussions involving nominations to federally authorized commissions HR 676 Expanded & Improved Medicare for All Act (all sections of full text) HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) Monitored Protecting Patients from Surprise Medical Bills Act (proposed legislation) Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017 Monitored S 397 Fair Medicare Hospital Payments Act of 2017 Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017

LobbyistCovered position, as disclosed
JACK S DEUSER —
JAMES C FREE —
ROBERT HICKMOTT —
TREVOR W. KOLEGO —
W. TIMOTHY LOCKE —
SUMMER MERSINGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 242 (115th), H.R. 1156 (115th), H.R. 1130 (115th), H.R. 676 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.